Collective Data Empowers Health Care Treatments

In 2020, Dell partnered with the i2b2 transSMART Foundation, a global nonprofit focused on enabling the promise of precision medicine to assist in creating virtual models of patients — known as digital medical twins. These twins are highly personalized to the patient and provide insights that facilitate precise recruitment into clinical trials. We started by focusing on COVID long-haul patients and are planning to expand to many more diseases, like cancer and neurological disease, as the program continues to expand and innovate. As of FY23, over 800,000 patients have had a digital twin created for them and used to provide precise recruitment into a clinical trial.